Ryght AI Announces Partnership with Biorasi to Transform Feasibility Accuracy in Clinical Trials

What You Should Know: – Ryght AI, an AI clinical trial developer, today announced a partnership with Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies. – The collaboration will bring advanced, AI-driven feasibility capabilities to biotech and biopharma sponsors.  Redefine...

• Published date: 15-08-2025 01:15 PM